What must the investigator check at appropriate intervals during the trial?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

What must the investigator check at appropriate intervals during the trial?

The main idea is that the investigator must verify that each participant is following the instructions for the investigational product(s) at appropriate intervals. This ongoing check is essential for participant safety and for the integrity of the trial data. In practice, it means reviewing how the IP is taken — including dosing, timing, route of administration, allowed/avoided concomitant meds, and any storage or handling requirements — and documenting any deviations. If a participant isn’t adhering, the investigator roles include counseling, adjusting guidance, and recording deviations as protocol violations or safety issues so they can be addressed and reported as needed. Other aspects like sponsor profits or packaging are handled through sponsor oversight and product accountability, not the ongoing patient-level check described here. Ensuring visits occur on schedule is important, but the critical focus at intervals during a trial is confirming that the IP is used as instructed, since that directly impacts safety and the reliability of study results.

The main idea is that the investigator must verify that each participant is following the instructions for the investigational product(s) at appropriate intervals. This ongoing check is essential for participant safety and for the integrity of the trial data. In practice, it means reviewing how the IP is taken — including dosing, timing, route of administration, allowed/avoided concomitant meds, and any storage or handling requirements — and documenting any deviations. If a participant isn’t adhering, the investigator roles include counseling, adjusting guidance, and recording deviations as protocol violations or safety issues so they can be addressed and reported as needed.

Other aspects like sponsor profits or packaging are handled through sponsor oversight and product accountability, not the ongoing patient-level check described here. Ensuring visits occur on schedule is important, but the critical focus at intervals during a trial is confirming that the IP is used as instructed, since that directly impacts safety and the reliability of study results.

More practice questions